- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Growth Potential Companies
Global Pharmaceuticals & Biotech High Growth Potential Companies
Results
489
Companies with a Future performance score of at least 3, ordered by Future performance score.
489 companies
Ascendis Pharma
Market Cap: US$9.8b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$162.84
7D
0.5%
1Y
20.5%
Travere Therapeutics
Market Cap: US$1.3b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$15.02
7D
-5.2%
1Y
102.4%
Alnylam Pharmaceuticals
Market Cap: US$39.7b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$304.56
7D
5.0%
1Y
105.2%
Zevra Therapeutics
Market Cap: US$467.5m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.55
7D
-1.2%
1Y
83.9%
AVITA Medical
Market Cap: US$148.6m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$5.62
7D
-10.5%
1Y
-41.5%
Axsome Therapeutics
Market Cap: US$5.2b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$105.16
7D
0.09%
1Y
40.7%
TG Therapeutics
Market Cap: US$5.1b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$35.11
7D
1.6%
1Y
115.0%
Pharma Mar
Market Cap: €1.5b
A biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€85.00
7D
-2.7%
1Y
124.6%
Innova Captab
Market Cap: ₹50.3b
An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.
INNOVACAP
₹878.45
7D
-1.4%
1Y
82.8%
Oscotec
Market Cap: ₩1.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩29,500.00
7D
10.9%
1Y
-3.6%
PharmaResearch
Market Cap: ₩4.7t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩451,000.00
7D
0.2%
1Y
208.7%
Camurus
Market Cap: SEK 30.0b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 511.50
7D
-1.2%
1Y
-15.5%
Xbrane Biopharma
Market Cap: SEK 344.1m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.22
7D
-5.5%
1Y
-24.6%
RemeGen
Market Cap: HK$32.5b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$48.20
7D
-5.9%
1Y
90.1%
ALTEOGEN
Market Cap: ₩17.6t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩330,000.00
7D
2.2%
1Y
77.5%
Acrux
Market Cap: AU$9.4m
Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.
ACR
AU$0.023
7D
0%
1Y
-71.6%
PharmaEssentia
Market Cap: NT$166.4b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$500.00
7D
-2.5%
1Y
17.0%
Bonesupport Holding
Market Cap: SEK 16.7b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 254.20
7D
-5.4%
1Y
3.2%
Sernova Biotherapeutics
Market Cap: CA$57.5m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.17
7D
-10.3%
1Y
-52.7%
Diamyd Medical
Market Cap: SEK 1.2b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 8.80
7D
-3.5%
1Y
-24.0%
Botanix Pharmaceuticals
Market Cap: AU$725.5m
Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.
BOT
AU$0.37
7D
4.2%
1Y
27.6%
Akeso
Market Cap: HK$75.2b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$83.80
7D
0.8%
1Y
90.5%
Neuland Laboratories
Market Cap: ₹147.6b
Manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹11,502.05
7D
3.0%
1Y
90.4%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥10.8b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥48.06
7D
-10.6%
1Y
-15.5%
argenx
Market Cap: €30.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€506.40
7D
-2.7%
1Y
45.8%
Ardelyx
Market Cap: US$878.1m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.67
7D
-7.6%
1Y
-47.0%
Innate Pharma
Market Cap: €181.9m
Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.
IPH
€1.97
7D
0.6%
1Y
-22.0%
Mereo BioPharma Group
Market Cap: US$341.9m
A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
MREO
US$2.15
7D
-4.0%
1Y
-37.7%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł155.7m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł33.40
7D
-5.4%
1Y
-54.2%
Wedge IndustrialLtd
Market Cap: CN¥6.7b
Engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China.
000534
CN¥14.03
7D
0.1%
1Y
24.0%
Evolus
Market Cap: US$592.5m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
EOLS
US$9.19
7D
-5.1%
1Y
-28.9%
Xiamen Amoytop Biotech
Market Cap: CN¥31.4b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥77.25
7D
3.6%
1Y
41.4%
Legend Biotech
Market Cap: US$5.3b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$28.95
7D
0.1%
1Y
-27.6%
Blueprint Medicines
Market Cap: US$6.5b
A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.
BPMC
US$101.35
7D
-0.1%
1Y
-4.0%
Guard Therapeutics International
Market Cap: SEK 367.1m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 18.20
7D
12.3%
1Y
-46.2%
Newron Pharmaceuticals
Market Cap: CHF 146.1m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 7.32
7D
-0.8%
1Y
-26.8%